Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

• Status: Recruiting
• Trial end date: 2020-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

In this study, the investigators will assess the efficacy of growth hormone co-stimulation to GnRH antagonist regimen in poor responders to COH for IVF.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Riyadh Fertility and Reproductive Health center
• Treatments: Hormones; Prolactin Release-Inhibiting Factors

Criteria

Inclusion Criteria:

• Serum anti-Müllerian hormone (AMH) less than 1.2 ng/ml

Exclusion Criteria:

-